⌘K
Loading ticker…
Karyopharm Therapeutics Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Karyopharm Therapeutics Inc. (KPTI) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 73. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.2%, relative volume 9.04×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 95, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
KPTI is in a stage 2 uptrend, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 15.0% / 38.9%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
KPTI is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $3M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $3M |
| VXFVanguard Extended Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KPTI Jan avg: -8.90% median: -9.71% win: 0% σ: 4.52% n: 4 2022-04-12 → 2026-05-29 | KPTI Feb avg: 18.90% median: 17.92% win: 50% σ: 35.61% n: 4 2022-04-12 → 2026-05-29 | KPTI Mar avg: -8.70% median: -6.00% win: 50% σ: 44.38% n: 4 2022-04-12 → 2026-05-29 | KPTI Apr avg: 13.83% median: -7.97% win: 40% σ: 48.60% n: 5 2022-04-12 → 2026-05-29 | KPTI May avg: -13.62% median: -5.91% win: 40% σ: 22.32% n: 5 2022-04-12 → 2026-05-29 | KPTI Jun avg: -14.21% median: -15.63% win: 25% σ: 13.36% n: 4 2022-04-12 → 2026-05-29 (current) | KPTI Jul avg: -0.71% median: -2.60% win: 50% σ: 10.97% n: 4 2022-04-12 → 2026-05-29 | KPTI Aug avg: 13.42% median: -2.03% win: 50% σ: 53.27% n: 4 2022-04-12 → 2026-05-29 | KPTI Sep avg: 3.44% median: 6.30% win: 75% σ: 7.87% n: 4 2022-04-12 → 2026-05-29 | KPTI Oct avg: -9.99% median: -12.07% win: 25% σ: 22.32% n: 4 2022-04-12 → 2026-05-29 | KPTI Nov avg: -4.52% median: -7.30% win: 25% σ: 11.51% n: 4 2022-04-12 → 2026-05-29 | KPTI Dec avg: -3.10% median: -3.82% win: 50% σ: 30.26% n: 4 2022-04-12 → 2026-05-29 |